GCT-12. OUTCOMES OF INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMOURS (NGGCT) TREATED AT A SINGLE UK PROTON CENTRE ACCORDING TO UK CHILDREN’S CANCER AND LEUKAEMIA GROUP (CCLG) GUIDANCE, INCLUDING EARLY IMPROVED OUTCOMES USING WHOLE VENTRICULAR RADIOTHERAPY (WVRT) FOR LOCALISED DISEASE

Love Goyal(Cancer Research UK), Gillian Whitfield(University of Manchester), D.J. Saunders, Thankamma Ajithkumar(University of Cambridge), Anna France(Proton (United Kingdom)), Simona Gaito(University of Manchester), James C. Nicholson(Institut Gustave Roussy), Matthew J. Murray(Cambridge University Hospitals NHS Foundation Trust), Nicky Thorp, Shermaine Pan(Proton (United Kingdom)), Rovel Colaco(Proton (United Kingdom))
Neuro-Oncology
June 18, 2024
10.1093/neuonc/noae064.267
Cited by 0

Related Papers

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease
|Neuro-Oncology|2013|371
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Life Cycle Assessment of Solar Photovoltaic Microgrid Systems in Off-Grid Communities
|Environmental Science & Technology|2016|87
A model for decoding resistance in precision oncology: acquired resistance to FGFR inhibitors in cholangiocarcinoma
|Annals of Oncology|2024|33
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
|JCO Global Oncology|2021|11